ENVUTEG Tablet Ref.[51211] Active ingredients: Dolutegravir Lamivudine Tenofovir disoproxil

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2021  Publisher: Mylan (Pty) Ltd, 4 Brewery Street, Isando, Johannesburg, 1609, Republic of South Africa

Product name and form

ENVUTEG Film coated tablet.

Pharmaceutical Form

Film coated tablets.

White to off white, film coated, capsule shaped, biconvex, bevelled edge tablet debossed with “M” on one side of the tablet and “LD” on the other side.

Qualitative and quantitative composition

Each ENVUTEG film coated tablet contains:

Lamivudine 300 mg.
Tenofovir alafenamide 25 mg.
Dolutegravir sodium (equivalent to dolutegravir) 50 mg.

Contains sugar: mannitol 131,40 mg and lactose monohydrate 60 mg per tablet.

For full list of excipients, see section 6.1.

Active Ingredient Description
Dolutegravir

Dolutegravir inhibits HIV integrase by binding to the integrase active site and blocking the strand transfer step of retroviral Deoxyribonucleic acid (DNA) integration which is essential for the HIV replication cycle.

Lamivudine

Lamivudine is a nucleoside analogue which has activity against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Its main mode of action is as a chain terminator of viral reverse transcription.

Tenofovir disoproxil

Tenofovir disoproxil is absorbed and converted to the active substance tenofovir, which is a nucleoside monophosphate analogue. Tenofovir is then converted to the active metabolite, tenofovir diphosphate, an obligate chain terminator, by constitutively expressed cellular enzymes. Tenofovir diphosphate inhibits HIV-1 reverse transcriptase and the HBV polymerase by direct binding competition with the natural deoxyribonucleotide substrate and, after incorporation into DNA, by DNA chain termination.

List of Excipients

Croscarmellose sodium
Lactose monohydrate
Magnesium stearate
Mannitol
Microcrystalline cellulose
Povidone
Sodium starch glycolate
Opadry II White

Pack sizes and marketing

The product is presented in the following marketable packs:

30’s Bottle Pack (with 4 g Molecular Sieve):

Pack TypeConfig-urationPrimary packaging components
HDPE Bottle Pack (with desiccant) 30’s countContainer: Bottle HDPE 60 ml 33 mm Blue round (12 G) TP
Closure: Closure 33 mm Blue screw with SG100 SP.
Desiccant: 2 g Molecular Sieve Canister-SC (2 No.s)

Marketing authorization holder

Mylan (Pty) Ltd, 4 Brewery Street, Isando, Johannesburg, 1609, Republic of South Africa

Marketing authorization dates and numbers

03/08/2021

Drugs

Drug Countries
ENVUTEG South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.